UPXI logo

UPEXI INC

UPXINASDAQ
πŸ† #3648 by market capEarnings Sep 2US Equity
$0.80β–Ό $0.00 (βˆ’0.21%)
πŸŒ… Pre-market$0.77β–Ό 3.60%Regular close Β· extended-hours price shown
1hβ€”
24hβ–Ό 0.2%
7dβ–Ό 5.1%
14dβ–² 1.4%
30dβ–² 5.9%
1yβ–Ό 88.0%
🏦Market Cap
$59M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-39.2%
Declining
πŸ“ŠGross Margin
86.0%
High
πŸ’΅FCF Margin
-83.1%
Thin
βš–οΈP/S Ratio
2.3x
Cheap
Otter Score
58
Weak

Trading Snapshot

Day Range
$0.80 – $0.82
52-Week Range
$0.54 – $9.12
Volume
$2.01B
Avg Volume
$2.10B
Shares Outstanding
73.5M
Next Earnings
Sep 10, 2026

Fundamentals Snapshot

Annual Revenue
$16M
Last Q Revenue
$5M
P/E Ratio
-0.2
P/S Ratio
2.3x
EPS (TTM)
$-3.49
Dividend Yield
0.00%

Why Investors Own UPXI

  • βœ“High-growth profile β€” revenue up +47.1% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 61% gross margin and 7% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$16Mβ–² +52.1% YoY
Gross Margin (TTM)
60.6%β–Ό βˆ’0.2% YoY
Operating Income (TTM)
$2Mβ–² +52.1% YoY
Free Cash Flow (TTM)
$1Mβ–² +52.1% YoY

About UPEXI INC

Upexi, Inc. engages in the development, manufacture, and distribution of consumer products. It offers nail grinder and healthy all-natural pet supplements under the LuckyTail brand; energy solutions under the PRAX brand; functional mushrooms under the Cure Mushrooms brand; cannabinoid under the Moonwlkr brand; and gummies and other products under the Gumi Labs brand name. The company sells its products through direct-to-consumer network, wholesale partnerships, and third-party platform. It also focuses on cryptocurrency industry and management of cash assets. The company was formerly known as Grove, Inc. and changed its name to Upexi, Inc. in August 2022. Upexi, Inc. was incorporated in 2018 and is headquartered in Tampa, Florida.

🦦

Otter Score Breakdown

β“˜
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
Overall Score
Weak
58/100

Analyst Ratings

β“˜
Consensus
Buy
8 analysts
Strong Buy2
Buy5
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates